Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**mir-142-3p mimic** is a synthetic small RNA oligonucleotide designed to replicate the function of the endogenous microRNA miR-142-3p. It is primarily used in research as a tool to artificially elevate miR-142-3p levels in cells or organisms to study its physiological and pathological roles. The mechanism of action involves downregulation of target mRNAs through RNA-induced silencing, notably affecting genes such as HMGB1, ADCY9, and Apc. This modulation leads to effects such as inhibition of neuroinflammation, increased cancer chemosensitivity, regulation of T cell function, and control of endothelial and mesenchymal cell differentiation. miR-142-3p mimic is most often used in research settings with indications including neuropathic pain, cancer (e.g., breast cancer drug resistance), vascular biology, autoimmune regulation, and inflammation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on mir-142-3p mimic.